Who Owns Drugs Made In America Acquisition II Stock?
NASDAQ: DMIIFinanceBlank ChecksUSD
At close: Oct 9, 4:00 PM ET · Delayed 15 min
Ownership breakdown
- Held by institutions
- 72.88%
- Held by insiders
- 15.21%
- Institutional holders
- 76
- Institutions 72.9%
- Insiders 15.2%
- Public and other 11.9%
Who owns Drugs Made In America Acquisition II stock?
Institutional investors own about 72.9% of Drugs Made In America Acquisition II's shares, spread across 76 institutions that file 13F reports. That level of institutional ownership is high, typical of large, widely followed companies. Insiders, including executives, directors and large founding shareholders, hold 15.21% of DMII.
The largest institutional holders are Karpus Management, Inc. (4.38%), MMCAP International, Inc. SPC (4.24%) and Magnetar Financial LLC (4.24%). Together, the top 10 institutions control 33.9% of shares outstanding. In their latest filings, 4 of the top 10 institutions increased their DMII positions and 1 reduced them.
Summary generated from market data by MetaCap's automated system. Methodology
Top institutional holders of DMII
| Institution | Shares | % Held | Change |
|---|---|---|---|
| Karpus Management, Inc. | 2.79M | 4.38% | +7.3% |
| MMCAP International, Inc. SPC | 2.70M | 4.24% | 0.0% |
| Magnetar Financial LLC | 2.70M | 4.24% | 0.0% |
| Glazer Capital LLC | 2.34M | 3.68% | -0.3% |
| Highbridge Capital Management, LLC. | 2.24M | 3.52% | +896.1% |
| Millennium Management Llc | 1.99M | 3.13% | +0.9% |
| Hudson Bay Capital Management Lp | 1.97M | 3.09% | 0.0% |
| Wolverine Asset Management, LLC | 1.86M | 2.91% | +3.3% |
| Polar Asset Management Partners Inc. | 1.50M | 2.35% | 0.0% |
| Tenor Capital Management Co., L.p. | 1.50M | 2.35% | 0.0% |
% held is the share of total shares outstanding. Change is the percentage change in the position since the holder's previous 13F filing.
Top mutual fund and ETF holders of DMII
| Fund | Shares | % Held |
|---|---|---|
| TRT for Professional Managers-CrossingBridge Low Duration High Income | 1.07M | 1.69% |
| INVESTMENT MANAGERS SERIES TRUST II-First Trust Merger Arbitrage Fund | 913.21K | 1.43% |
| Merger Fund-The Merger Fund | 515.37K | 0.81% |
| INVESTMENT MANAGERS SERIES TRUST II-First Trust Multi-Strategy Fund | 142.64K | 0.22% |
| RIVERNORTH OPPORTUNITIES FUND INC.-Rivernorth Opportunities Fund Inc | 100.00K | 0.16% |
| JNL Series Trust-JNL Multi-Manager Alternative Fund | 28.91K | 0.05% |
| Virtus Event Opportunities Trust-Virtus Westchester Event-Driven Fund | 27.18K | 0.04% |
| Brinker Capital Destinations TRT-Destinations Low Duration Fixed Incom | 26.30K | 0.04% |
| Virtus Event Opportunities Trust-Virtus Westchester Credit Event Fund | 15.75K | 0.02% |
| Principal Funds, Inc-Global Multi-Strategy Fund | 14.18K | 0.02% |
Frequently asked questions
Who is the largest shareholder of Drugs Made In America Acquisition II?
Karpus Management, Inc. is the largest institutional shareholder of DMII, owning 4.38% of shares outstanding (2.79M shares) as of its latest 13F filing.
What percentage of Drugs Made In America Acquisition II is owned by institutions?
Institutions own about 72.9% of DMII shares and 86.0% of the public float.
How much of Drugs Made In America Acquisition II do insiders own?
Insiders, such as officers and directors, own about 15.21% of DMII shares outstanding.
Where does institutional ownership data come from?
Investment managers with more than $100 million in US equities must file Form 13F with the SEC within 45 days of each quarter-end. Holdings are therefore up to about 4.5 months old when published.